IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Phase I Study of LBH589 & Erlotinib for Advanced Aerodigestive Tract Cancers
This study has been completed.
Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Collaborators:
Genentech, Inc.
Novartis
Information provided by (Responsible Party):
H. Lee Moffitt Cancer Center and Research Institute
ClinicalTrials.gov Identifier:
NCT00738751
First received: August 18, 2008
Last updated: February 3, 2015
Last verified: February 2015
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | February 2015 |
| Primary Completion Date: | August 2013 (Final data collection date for primary outcome measure) |